Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH

NCT05283993 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05283993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05283993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2021
Completion date
December 31, 2030
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, castleman's disease, cryoglobulinemia, heavy chain deposition disease, light chain deposition disease, monoclonal gammopathy of neurological significance (mgns), monoclonal gammopathy of renal significance (mgrs), monoclonal gammopathy of undetermined significance (mgus), multiple myeloma, plasma cell leukemia, polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin changes, smoldering multiple myeloma